RADLOVIC, MICHAEL – Trademark Portfolio
Entity Type: 01
RADLOVIC, MICHAEL has 31 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Filings span 8 Nice Classification classes, led by Class 36 (Insurance & Financial) and Class 5 (Pharmaceuticals). This trademark owner is based in Los Angeles, CA.
Law Offices of Gary L. Blum
3278 Wilshire Blvd.
Los Angeles, CA 90010
Showing of trademarks Trademarks
Trademark Classifications
RADLOVIC, MICHAEL's trademark portfolio spans 8 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does RADLOVIC, MICHAEL have?
RADLOVIC, MICHAEL has 31 U.S. trademarks filed with the USPTO.
What trademark classes does RADLOVIC, MICHAEL file in?
RADLOVIC, MICHAEL files trademarks across 8 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What is RADLOVIC, MICHAEL's trademark registration success rate?
RADLOVIC, MICHAEL has a 0% trademark registration rate, with 0 out of 30 resolved applications resulting in successful registration. Currently, 0 applications are pending review.